The Medicare GLP-1 Bridge is a short-term demonstration run by CMS (Centers for Medicare & Medicaid Services) that gives eligible Medicare Part D beneficiaries access to certain GLP-1 drugs from July 1, 2026 through December 31, 2027.

empty